Squamous Cell Carcinoma
See also the article on precancerous lesions preceding squamous cell carcinoma Precancerous Lesions Preceding Squamous Cell Carcinoma (Actinic Keratosis and Carcinoma in Situ, or Bowen's Disease).
Essentials
- Squamous cell carcinoma (SCC, epidermoid/spinocellular/squamocellular carcinoma) develops from the epidermal cells as a result of long term exposure to UV radiation.
- It may metastasise to nearby lymph nodes.
- SCC may arise directly on healthy looking skin, but more frequently it develops on a precancerous lesion, such as:
- SCC is always treated surgically in specialized care.
- Immunosuppressive therapy lasting for several years, e.g. in organ transplant recipients, predisposes the patient to SCC.
Diagnosis
- SCC is usually a clearly demarcated, reddish or skin-coloured nodule frequently with a hyperkeratotic and ulcerated surface (picture ).
- No telangiectasias are present on the surface as is the case in typical basal cell carcinoma (BCC) Basal Cell Carcinoma.
- SCC is often a rapidly growing and partly ulcerated skin tumour on areas of skin unprotected against the sun, such as the face, the backs of the hands or lower legs.
- The final diagnosis is histological.
- The risk of metastasis depends on:
- tumour-related risk factors, such as location in a risk area (ear lobe, lip, scalp), large size, thickness, rapid growth, histological type
- patient-related risk factors, such as immunosuppressive medication, history of radiotherapy to or chronic inflammation of the tumour area.
- Keratoacanthoma is a rapidly growing well differentiated SCC (pictures ).
Treatment
- SCC is treated surgically in specialized care.
- There should be at least a 5-mm margin of healthy tissue (a histological margin of at least 2 mm).
- In cases with a high risk of recurrence, wider surgical margins are recommended depending on surgical possibilities.
- Examinations to exclude metastasis to lymph nodes (imaging, sentinel lymph nodes) should be performed on a case by case basis.
- The frequency and length of follow-up is determined by the risk of recurrence and the stage of the tumour.
- Keratoacanthoma is a SCC with low risk of recurrence. A 5-mm margin of healthy tissue should be aimed at in its removal.
Specialist consultation
- If SCC is diagnosed by skin biopsy or excision of a skin lesion in primary health care, the patient should be referred to specialized care.
SCC of the lip
- Most commonly encountered on the lower lip (pictures ).
- Starts as a sore or ulcer usually preceded by actinic cheilitis or leukoplakia.
- Lip cancer is managed surgically in specialized care by excising the tumour with adequate margins followed by a reconstruction.
- Lip cancer may metastasise to the lymph nodes under the lower jaw, and these should be palpated at follow-up examinations.
References
- Stratigos AJ, Garbe C, Dessinioti C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023. Eur J Cancer 2023;(193):113251 [PubMed]
- Stratigos AJ, Garbe C, Dessinioti C, et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023. Eur J Cancer 2023;(193):113252 [PubMed]
- Dessinioti C, Stratigos AJ. Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2022;36 Suppl 1():11-18 [PubMed]
- Keohane SG, Botting J, Budny PG, et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol 2021;184(3):401-414 [PubMed]
- Zeng S, Fu L, Zhou P, et al. Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis. PLoS One 2020;15(9):e0239586 [PubMed]
- Ali Z, Todd PM. Total body skin examination increases squamous cell carcinoma detection: a retrospective cohort study. Clin Exp Dermatol 2020;45(1):86-88 [PubMed]
- Work Group, Invited Reviewers, Kim JYS, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol 2018;78(3):560-578 [PubMed]